NCR Online Journal

The growing geriatric population is expected to drive the growth of Drug-Eluting Stents market

 Breaking News
  • No posts were found

The growing geriatric population is expected to drive the growth of Drug-Eluting Stents market

November 24
21:23 2021
The growing geriatric population is expected to drive the growth of Drug-Eluting Stents market
Drug-Eluting Stents Market
The Drug-Eluting Stents market is expected to grow due to a change in preference for drug-eluting stents over angioplasty.

DelveInsight’s Drug-Eluting Stents market report provides a thorough comprehension of Drug-Eluting Stents and historical and forecasted Drug-Eluting Stents market trends in the 7MM (the United States, EU5 (Germany, France, Spain, Italy, and the United Kingdom), and Japan). 

Some of the Key Highlights from the Drug-Eluting Stents Market Report

  • The major companies active in the Drug-Eluting Stents market include Abbott, Braun Melsungen AG, Biosensors International Group, Ltd, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, Terumo Corporation, Medtronic, MicroPort Scientific Corporation, Lepu Medical, Cook, Medinol Ltd, Cardinal Health, among others.

  • The FDA-approved Drug-Eluting Stents available in the market include EluNIR, SYNERGY™ XD, XIENCE SIERRA, Coroflex® ISAR NEO, BA9™, Orsiro, and several others.

  • SYNERGY XD by Boston Scientific Corporation is a bioabsorbable everolimus-eluting stent of the next generation.

  • EluNIR by Medinol is the first drug-eluting stent made of elastomeric material. It’s made from a thin cobalt-chrome alloy. Ridaforolimus Eluting Coronary Stent System is a stent known for its unique flexibility, conformability, and scaffolding.

  • The Drug-Eluting Stents market is segmented by Type, Scaffold, and End Users.

Request for the Webex demo of the report @ Drug-Eluting Stents Market Outlook

Drug-Eluting Stents: Overview

Stents are small, expandable tubes that are inserted following percutaneous coronary intervention (PCI) to keep arteries open and improve blood flow. Stents are divided into two types: bare-metal stents and drug-eluting stents. Drug-Eluting Stents are coated with medications that slowly elute to prevent scar tissue buildup in the artery lining.

Drug-Eluting Stents Market

The total Drug-Eluting Stents market size is segmented by type, which includes coronary and peripheral stents. The Drug-Eluting Stents market is expected to grow due to a shift in preference for drug-eluting stents over angioplasty. The Drug-Eluting Stents market is expected to grow due to a change in preference for drug-eluting stents over angioplasty. The growing burden of the elderly population, combined with a sedentary lifestyle, is expected to increase the prevalence of atherosclerosis, thereby fueling the Drug-Eluting Stents market. Furthermore, the demand for minimally invasive procedures is a driving factor.

Find out which player or device is going to get the maximum share @ Drug-Eluting Stents Market Size

Drug-Eluting Stents Key Companies 

  • Abbott

  • Braun Melsungen AG

  • Biosensors International Group, Ltd

  • BIOTRONIK SE & Co. KG

  • Boston Scientific Corporation

  • Terumo Corporation

  • Medtronic

  • MicroPort Scientific Corporation

  • Lepu Medical

  • Cook

  • Medinol Ltd

  • Cardinal Health

Drug-Eluting Stents Market Drivers

  • Increase in prevalence of artery blockage due to sedentary lifestyle and growing geriatric population

  • Technological advancement in the field of drug-eluting stenting

Drug-Eluting Stents Market Barriers

  • The risk associated with the stents

  • The dearth of skilled healthcare professionals

Drug-Eluting Stents Unmet Needs 

  • Incomplete inhibition of restenosis (especially in complex lesions)

Scope for the Report

Coverage: 7MM (the US, EU5 (the UK, Germany, Italy, Spain, and France) and Japan)

Study Period: 2018-26

Drug-Eluting Stents Key Companies: Abbott, Braun Melsungen AG, Biosensors International Group, Ltd, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, Terumo Corporation, Medtronic, MicroPort Scientific Corporation, Lepu Medical, Cook, Medinol Ltd, Cardinal Health, among others. 

Tools Used: PEST Analysis

KOL’s Views

Table of Contents 

1.

Key Insights

2.

Executive Summary of Drug-Eluting Stents 

3.